These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37312906)

  • 1. Evaluation of polymorphisms and expression of
    Męcińska-Jundziłł K; Tadrowski T; Jundziłł A; Witmanowski H; Czajkowki R
    Postepy Dermatol Alergol; 2023 Apr; 40(2):225-233. PubMed ID: 37312906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
    Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
    Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of PTPN22 gene polymorphism with non-segmental vitiligo in South Indian Tamils.
    Rajendiran KS; Rajappa M; Chandrashekar L; Thappa DM
    Postepy Dermatol Alergol; 2018 Jun; 35(3):280-285. PubMed ID: 30008646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the association between
    Li J; Yan M; Zhang Y; Feng C; Wang H; Wang C; Sun L
    Oncotarget; 2017 Oct; 8(50):88179-88188. PubMed ID: 29152150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP1, PTPN22 and PADI4 gene polymorphisms and rheumatoid arthritis in ACPA-positive Singaporean Chinese.
    Goh LL; Yong MY; See WQ; Chee EYW; Lim PQ; Koh ET; Leong KP;
    Rheumatol Int; 2017 Aug; 37(8):1295-1302. PubMed ID: 28653215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Association between PTPN22 Gene +1858 C>T Polymorphism and Susceptibility to Generalized Vitiligo in a Turkish Population.
    Akbas H; Dertlioglu SB; Dilmec F; Atay AE
    Ann Dermatol; 2014 Feb; 26(1):88-91. PubMed ID: 24648691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CTLA-4 +49 A/G, CT60 A/G and PTPN22 1858 C/T polymorphisms and susceptibility to vitiligo: a meta-analysis.
    Song GG; Kim JH; Lee YH
    Mol Biol Rep; 2013 Apr; 40(4):2985-93. PubMed ID: 23264102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.
    LaBerge GS; Bennett DC; Fain PR; Spritz RA
    J Invest Dermatol; 2008 Jul; 128(7):1757-62. PubMed ID: 18200060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the Role of Interleukin 6 in Vitiligo Pathogenesis.
    Singh M; Jadeja SD; Vaishnav J; Mansuri MS; Shah C; Mayatra JM; Shah A; Begum R
    Immunol Invest; 2022 Jan; 51(1):120-137. PubMed ID: 32865069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients.
    Ozel Turkcu U; Solak Tekin N; Gokdogan Edgunlu T; Karakas Celik S; Oner S
    Gene; 2014 Feb; 536(1):129-34. PubMed ID: 24333267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of neuregulin1 in the lesional skin of vitiligo patients.
    Rani S; Kumari U; Bhardwaj S; Parsad D; Sharma VL; Kumar R
    Int J Dermatol; 2019 Feb; 58(2):242-249. PubMed ID: 30074619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease.
    Horie Y; Saito W; Kitaichi N; Miura T; Ishida S; Ohno S
    Jpn J Ophthalmol; 2011 Jan; 55(1):57-61. PubMed ID: 21331694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatase PTPN22 +1858C/T polymorphism is associated with active vitiligo.
    Garcia-Melendez ME; Salinas-Santander M; Sanchez-Dominguez C; Gonzalez-Cardenas H; Cerda-Flores RM; Ocampo-Candiani J; Ortiz-López R
    Exp Ther Med; 2014 Nov; 8(5):1433-1437. PubMed ID: 25289035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.
    Jadeja SD; Mansuri MS; Singh M; Dwivedi M; Laddha NC; Begum R
    PLoS One; 2017; 12(7):e0180958. PubMed ID: 28700671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasome activation and vitiligo/nonsegmental vitiligo progression.
    Marie J; Kovacs D; Pain C; Jouary T; Cota C; Vergier B; Picardo M; Taieb A; Ezzedine K; Cario-André M
    Br J Dermatol; 2014 Apr; 170(4):816-23. PubMed ID: 24734946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population.
    Jin Y; Birlea SA; Fain PR; Spritz RA
    J Invest Dermatol; 2007 Nov; 127(11):2558-62. PubMed ID: 17637824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1).
    Jin Y; Riccardi SL; Gowan K; Fain PR; Spritz RA
    J Invest Dermatol; 2010 Mar; 130(3):774-83. PubMed ID: 19727120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-196a-2 rs11614913 polymorphism is associated with vitiligo by affecting heterodimeric molecular complexes of Tyr and Tyrp1.
    Cui TT; Yi XL; Zhang WG; Wei C; Zhou FB; Jian Z; Wang G; Gao TW; Li CY; Li K
    Arch Dermatol Res; 2015 Oct; 307(8):683-92. PubMed ID: 25896941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Nod-like receptor protein-1 (rs2670660) and Toll-like receptor-4 (rs4986790) with non-segmental vitiligo: A case-control study in South Indian population.
    Rajendiran KS; Rajappa M; Chandrashekar L; Thappa DM
    Int J Immunogenet; 2019 Oct; 46(5):321-330. PubMed ID: 31293094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Functional Polymorphism in Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) Gene with Vitiligo.
    Huraib GB; Al Harthi F; Arfin M; Aljamal A; Alrawi AS; Al-Asmari A
    Biomark Insights; 2020; 15():1177271920903038. PubMed ID: 32076368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.